Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Vitroscope logo — Enabling breakthrough cell culture models by leveraging perf...

Vitroscope

Enabling breakthrough cell culture models by leveraging perfusion & automation.

Founded 2019 Norway Norway 6 employees Seed Total: $530.00K Biotechnology, Life Sciences

General Information

Company Name Vitroscope
Founded Year 2019
Location Norway Norway +1
Employees 6
Industries Biotechnology, Life Sciences
Funding Stage Seed
Social

Get notified when Vitroscope moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vitroscope

Vitroscope, founded in 2019 and headquartered in Norway, is pioneering advancements in the Biotechnology and Life Sciences industries. The company is known for its slogan: "Enabling breakthrough cell culture models by leveraging perfusion & automation."

With a transformative platform, Vitroscope facilitates the study of immune activity, drug effects, and disease mechanisms by maintaining the native microenvironment of living human tissues. Their integrated system supports various applications, including tissue, 2D, mechanobiology, organoids, and 3D bioprints, while ensuring compatibility with both up- and downstream screenings.

In terms of funding, Vitroscope last received a seed investment on 01 December 2021 from StartupLab. This strategic financial backing positions the company to further innovate and expand its reach in the field of human tissue study.

Taxonomy: Cell Culture Models, Perfusion Technology, Vascularised Organoids, Microenvironment Control, Drug Effects Study, Immune Activity Study, Disease Mechanism Study, Mechanobiology, Organoid Technology, Ex Vivo Tissue Research, Biomedical Engineering, 3D Bioprints, Live Cell Analysis

Services & Products

Controlled Flow for Vascularised Organoids
Preservation of Native Microenvironment
Ex Vivo Tissue Culture Solutions
Dynamic Culture Systems
Real-Time Supernatant Monitoring
Custom Experiment Protocols

Target Customers

Research Institutions Biotechnology Companies Pharmaceutical Companies Academic Researchers Medical Researchers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• 1
Investor
01 Dec 2021
Grant •••••• 1
Investor
01 Nov 2020
Grant •••••• 1
Investor
01 Oct 2019

Latest News

View All
Nordic early-stage startups to watch - according to investors — Sifted
Nordic early-stage startups to watch - according to investors
Sifted Jun 07, 2024

Vitroscope Alternatives & Competitors

View All Alternatives
Vitroscope vs
Visikol
Visikol United States

Advanced imaging, digital pathology and 3D cell culture drug discovery services.

Grant
14 employees
Analytics, Biotechnology
Vitroscope vs
AKF Plant Sciences
AKF Plant Sciences India

Enhancing Agricultural Innovations

6 employees
Agriculture, Biotechnology
Vitroscope vs
3D Genomics
3D Genomics United States

We work with you to design the study, build the best cell models and develop informative data analys...

1 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Vitroscope

Enabling breakthrough cell culture models by leveraging perfusion & automation.
Vitroscope was founded in 2019.
Vitroscope is headquartered in Norway.
Vitroscope operates in the following industries: Biotechnology, Life Sciences.
Vitroscope has approximately 6 employees.
Vitroscope has completed 3 funding rounds, raising a total of $530.00K. The latest funding stage is Seed.
Vitroscope offers: Controlled Flow for Vascularised Organoids, Preservation of Native Microenvironment, Ex Vivo Tissue Culture Solutions, Dynamic Culture Systems, Real-Time Supernatant Monitoring, Custom Experiment Protocols.
Top alternatives and competitors to Vitroscope include Visikol, AKF Plant Sciences, 3D Genomics , ASC Oncology GmbH, Spares Service & Machinery. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vitroscope and Visikol are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vitroscope and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy